OWP
SCPH

Old Well Partners’s scPharmaceuticals SCPH Stock Holding History

Old Well Partners’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,666
Closed -$109K – 50
2020
Q3 		$109K Buy
+14,666
New +$115K 0.1% 29
2020
Q1 		– Sell
-10,852
Closed -$61K – 33
2019
Q4 		$61K Buy
+10,852
New +$55.5K 0.05% 28

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Old Well Partners's SCPH Position: Q4 2020 in Review

Old Well Partners sold out of scPharmaceuticals (SCPH) in Q4 2020, closing a stake of 14,666 shares — an estimated $109K sold.

Old Well Partners first reported a position in SCPH in Q4 2019 and held it in 2 quarters. The position peaked at $109K in Q3 2020. 47 funds tracked by Wall St. Rank hold SCPH as of Q4 2020.

  • Old Well Partners reported no remaining scPharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Old Well Partners sold 14,666 scPharmaceuticals shares in Q4 2020, an estimated $109K.
  • Old Well Partners first reported a position in scPharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Old Well Partners's scPharmaceuticals position peaked at $109K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2020.

Based on Old Well Partners's 13F filing for Q4 2020, filed 16 Feb 2021.